• Tailoring Bruton Tyrosine Kinase Inhibitor Strategies for CLL: Managing Today, Anticipating Tomorrow

  • Apr 26 2024
  • Length: 38 mins
  • Podcast
Tailoring Bruton Tyrosine Kinase Inhibitor Strategies for CLL: Managing Today, Anticipating Tomorrow By cover art

Tailoring Bruton Tyrosine Kinase Inhibitor Strategies for CLL: Managing Today, Anticipating Tomorrow

Listen for free

View show details

  • Summary

  • Are you selecting the right Bruton tyrosine kinase (BTK) inhibitor for your patients with chronic lymphocytic leukemia (CLL)? Experts discuss the key differentiators and upcoming developments in the field.

    Credit available for this activity expires: 04/26/25
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000717?ecd=bdc_podcast_libsyn_mscpedu
    Show more Show less
Physical Illness & Disease Hygiene & Healthy Living
Show more Show less

What listeners say about Tailoring Bruton Tyrosine Kinase Inhibitor Strategies for CLL: Managing Today, Anticipating Tomorrow

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available